Physician profile
Chan Yeu Pu
NPI 1558761890
$2,248.97
in general payments reported to CMS, 2019-2025
12 companies · $296 in 2025
The $296 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $257 · 2023: $1,566 · 2024: $131 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,079 · Travel and Lodging: $913.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,079.35 |
| Travel and Lodging | $913.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $721.06 | 2023 | Da Vinci Surgical System, Da Vinci Sp |
| Pinnacle Biologics, INC | $300.78 | 2023 | Photofrin |
| Astrazeneca Pharmaceuticals LP | $274.87 | 2019-2025 | Breztri, Fasenra |
| Olympus America INC. | $272.10 | 2023-2025 | Spiration Valve System |
| Pulmonx Corporation | $231.93 | 2023-2025 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Boston Scientific Corporation | $135.66 | 2023 | Ultraflex Esophageal Ng |
| Genentech USA, INC. | $124.96 | 2019 | |
| Steris Corporation | $78.40 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.16 | 2024 | Ofev |
| Mylan Specialty L.P. | $29.73 | 2024 | Yupelri |
| Glaxosmithkline, LLC. | $27.73 | 2023 | Nucala |
| Regeneron Healthcare Solutions, INC. | $18.59 | 2024 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chan Yeu Pu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.